<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03211260</url>
  </required_header>
  <id_info>
    <org_study_id>319_2017bis</org_study_id>
    <nct_id>NCT03211260</nct_id>
  </id_info>
  <brief_title>Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease</brief_title>
  <official_title>Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease: a Open, Single-arm Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ASST Gaetano Pini-CTO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Grigioni per il Morbo di Parkinson</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Policlinico San Matteo Pavia Fondazione IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ASST Gaetano Pini-CTO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Freezing of gait (FOG) is a common disabling condition in Parkinson's disease (PD), causes
      falls, and impairs quality of life. Therapeutic options for this symptom are limited and of
      limited efficacy. Besides, the pathophysiology has been not clarified yet. Proprioceptive
      sensitivity is likely to play a role and recent studies have reported that high-frequency
      microfocal vibratory stimulation exert a modulatory effect of proprioceptive reflex circuits
      and could be considered a valuable treatment strategy. However, evidence is not available.
      The present study was designed to collect preliminary evidence of efficacy of a vibrotactile
      device (Equistasi) for the treatment of FOG.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 11, 2017</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freezing of gait questionnaire severity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in freezing of gait questionnaire score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gait and Falls Questionnaire (GFQ) score</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in the GFQ score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in quality of life measured using the 39-item Parkinson's Disease Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Falls</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number of falls recorded during the intervention period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment continuation</measure>
    <time_frame>4 weeks</time_frame>
    <description>Likelihood that patients would continue taking the trial treatment as assessed by a self-rating scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Freezing of Gait</condition>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>EQUISTASI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EQUISTASI</intervention_name>
    <description>Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.</description>
    <arm_group_label>EQUISTASI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with Parkinson's Disease

          -  Stable drug therapy response without any change in the 3 months before the study.

          -  written informed consent

        Exclusion Criteria:

          -  Hoehn-Yahr stage â‰¥ 4

          -  Cognitive decline (Mini Mental State Examination &lt;26)

          -  Systemic illness involving the nervous system

          -  Diabetes

          -  Presence of cardiac pacemaker

          -  Presence of deep brain stimulation

          -  Presence of severe dysautonomia with marked hypotension

          -  History or active neoplasia

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianni Pezzoli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Parkinson, ASST Gaetano Pini-CTO di Milano</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gianni Pezzoli, MD</last_name>
    <phone>+390257993222</phone>
    <email>gianni.pezzoli@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emanuele Cereda, MD, PhD</last_name>
    <phone>+390382501484</phone>
    <email>e.cereda@smatteo.pv.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro Parkinson, ASST Gaetano Pini-CTO</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianni Pezzoli, MD</last_name>
      <phone>+390257993222</phone>
      <email>gianni.pezzoli@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2017</study_first_submitted>
  <study_first_submitted_qc>July 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ASST Gaetano Pini-CTO</investigator_affiliation>
    <investigator_full_name>Gianni Pezzoli</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>Freezing of gait</keyword>
  <keyword>Equistasi</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

